Follow
Ibrahim H. Eissa
Ibrahim H. Eissa
Professor, Faculty of pharmacy, Al-Azhar University
Verified email at azhar.edu.eg
Title
Cited by
Cited by
Year
Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor
AA Al-Karmalawy, MA Dahab, AM Metwaly, SS Elhady, EB Elkaeed, ...
Frontiers in Chemistry 9, 661230, 2021
1592021
Design, synthesis and anticancer evaluation of thieno [2, 3-d] pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers
SA Elmetwally, KF Saied, IH Eissa, EB Elkaeed
Bioorganic chemistry 88, 102944, 2019
1432019
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
HA Mahdy, MK Ibrahim, AM Metwaly, A Belal, ABM Mehany, ...
Bioorganic Chemistry 94, 103422, 2020
1332020
Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene) thiazolidin-2-ylidene) amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and …
WM Eldehna, MF Abo-Ashour, A Nocentini, P Gratteri, IH Eissa, M Fares, ...
European journal of medicinal chemistry 139, 250-262, 2017
1272017
Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors
AGA El‐Helby, H Sakr, IH Eissa, H Abulkhair, AA Al‐Karmalawy, K El‐Adl
Archiv der Pharmazie 352 (10), 1900113, 2019
1232019
Design, synthesis and anticancer evaluation of 1H-pyrazolo [3, 4-d] pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers
AA Gaber, AH Bayoumi, AM El-Morsy, FF Sherbiny, ABM Mehany, ...
Bioorganic chemistry 80, 375-395, 2018
1202018
Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo [3, 4-b] pyridine derivatives as potential anticancer agents
IH Eissa, AM El-Naggar, MA El-Hashash
Bioorganic chemistry 67, 43-56, 2016
1202016
Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors
MK Ibrahim, MS Taghour, AM Metwaly, A Belal, ABM Mehany, ...
European journal of medicinal chemistry 155, 117-134, 2018
1092018
Traditional ancient Egyptian medicine: A review
AM Metwaly, MM Ghoneim, IH Eissa, IA Elsehemy, AE Mostafa, ...
Saudi journal of biological sciences 28 (10), 5823-5832, 2021
1072021
Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR WT and EGFR T790M
AA Nasser, IH Eissa, MR Oun, MA El-Zahabi, MS Taghour, A Belal, ...
Organic & biomolecular chemistry 18 (38), 7608-7634, 2020
1052020
New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies
H Elkady, A Elwan, HA El-Mahdy, AS Doghish, A Ismail, MS Taghour, ...
Journal of enzyme inhibition and medicinal chemistry 37 (1), 403-416, 2022
1042022
Benzoxazole/benzothiazole‐derived VEGFR‐2 inhibitors: design, synthesis, molecular docking, and anticancer evaluations
AGA El‐Helby, H Sakr, IH Eissa, AA Al‐Karmalawy, K El‐Adl
Archiv der Pharmazie 352 (12), 1900178, 2019
912019
Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents
SA El-Metwally, MM Abou-El-Regal, IH Eissa, ABM Mehany, HA Mahdy, ...
Bioorganic Chemistry 112, 104947, 2021
872021
Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors
KM El-Gamal, AM El-Morsy, AM Saad, IH Eissa, M Alswah
Journal of Molecular Structure 1166, 15-33, 2018
872018
Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists
MK Ibrahim, IH Eissa, MS Alesawy, AM Metwaly, MM Radwan, ...
Bioorganic & medicinal chemistry 25 (17), 4723-4744, 2017
862017
Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents
MA El-Zahabi, H Sakr, K El-Adl, M Zayed, AS Abdelraheem, SI Eissa, ...
Bioorganic chemistry 104, 104218, 2020
842020
Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19)
A El-Demerdash, AM Metwaly, A Hassan, TM Abd El-Aziz, EB Elkaeed, ...
Biomolecules 11 (3), 460, 2021
812021
Design, synthesis, docking, DFT, MD simulation studies of a new nicotinamide-based derivative: in vitro anticancer and VEGFR-2 inhibitory effects
EB Elkaeed, RG Yousef, H Elkady, IMM Gobaara, BA Alsfouk, DZ Husein, ...
Molecules 27 (14), 4606, 2022
792022
Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPARγ and SUR agonists
MK Ibrahim, IH Eissa, AE Abdallah, AM Metwaly, MM Radwan, ...
Bioorganic & medicinal chemistry 25 (4), 1496-1513, 2017
792017
Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme
K El-Adl, AGA El-Helby, H Sakr, IH Eissa, SSA El-Hddad, FMIA Shoman
Bioorganic chemistry 102, 104059, 2020
782020
The system can't perform the operation now. Try again later.
Articles 1–20